Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › CLYM

SUPERSTRING CAPITAL MANAGEMENT LP position in CLYM

CLIMB BIO INC · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 521,082 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$6.8M, representing 4.29% of its reported portfolio and ranking #11 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CLYM holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)521.08K sh
Reported value held$6.79M
Portfolio Weight4.29%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's CLYM position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in CLYM in Q3 2024 at 33,824 shares (US$172K). The position peaked in Q2 2026 at 521,082 shares, worth US$6.8M. Across 4 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 521,082 shares valued at US$6.8M — an increase of 321,873 shares quarter over quarter.. Notable position changes include a 190% increase in Q4 2024 (shares fell 32% over the following quarter), a 162% increase in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 33.82K $172.16K New
Q4 2024 98.16K $176.69K Add
Q1 2026 199.21K $1.36M New
Q2 2026 521.08K $6.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLYM and 13F data

CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLYM

All CLYM fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held CLYM?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CLYM holdings in 4 of the last 8 reported quarters, going back to Q3 2024.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in CLYM?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 521.08K shares of CLYM (CLIMB BIO INC), valued at $6.79M, representing 4.29% of its reported portfolio and ranking #11.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling CLYM?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in CLYM. The position peaked in Q2 2026 at 521.08K shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.